India betamethasone market is expected
to grow at a steady rate during the forecast period. The India betamethasone
market is driven by the widespread use of the drug for the treatment of a wide
range of skin disorders including eczema, psoriasis, among others.
Additionally, the increasing use of the medication in several rheumatic
disorders such as rheumatoid arthritis, systemic lupus erythematosus, among
others is further expected to fuel the market growth over the next few years.
Besides, benefits such as easy availability and administration through
different routes of administration such as oral, intravenous and topical are
further expected to positively influence the market growth through FY2026.
Also, the betamethasone cream and ointment are a part of the WHO’s list of
essential medicines.
The India betamethasone market is
segmented based on source, type, form, route of administration, distribution
channel, application, end user, company and region. Based on distribution
channel, the market can be split into online and offline. The offline channel
is expected to dominate the market owing to the consumer preference for buying
medicines from a pharmacy or drug store.
The major players operating in the India
betamethasone market are Envee Drugs Pvt. Ltd., GlaxoSmithKline Pharmaceuticals
Ltd, Dermocare Laboratories (Guj.) Pvt Ltd, Emson Medichem Pvt. Ltd, Cipla
Limited, East West Pharma, Omega Remedies Pvt Ltd, Moraceae Pharmaceuticals
Pvt. Ltd., Micro Labs Ltd, Pharmtak Ophtalmics Pvt. Ltd. and others. Major
companies are developing advanced technologies, receiving approvals from
regulatory bodies and launching new products in order to stay competitive in
the market. Other competitive strategies include mergers & acquisitions and
new product developments.
Years
considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the Study:
- To analyze and estimate the market size of India betamethasone market
from FY2016 to FY2019.
- To estimate and forecast the market size of India betamethasone market
from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India betamethasone market based on source,
type, form, route of administration, distribution channel, application,
end user, company and regional distribution.
- To identify dominant region or segment in the India betamethasone market.
- To identify drivers and challenges for India betamethasone market.
- To examine competitive developments such as expansions, new product
launches, mergers & acquisitions, etc., in India betamethasone market.
- To identify and analyze the profile of leading players operating in
India betamethasone market.
- To identify key sustainable strategies adopted by market players in
India betamethasone market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive
secondary research for this study. Initially, TechSci Research sourced a list
of manufacturers across the globe. Subsequently, TechSci Research conducted
primary research surveys with the identified companies. While interviewing, the
respondents were also enquired about their competitors. Through this technique,
TechSci Research could include the manufacturers which could not be identified
due to the limitations of secondary research. TechSci Research analyzed the manufacturers,
distribution channels and presence of all major players across the globe.
TechSci
Research calculated the market size of India betamethasone market using a bottom-up approach, wherein data for various end-user segments
was recorded and forecast for the future years. TechSci Research sourced these
values from the industry experts and company representatives and externally
validated through analyzing historical data of these product types and
applications for getting an appropriate, overall market size. Various secondary
sources such as company websites, news articles, press releases, company annual
reports, investor presentations and financial reports were also studied by
TechSci Research.
Key Target Audience:
- Betamethasone manufacturers/ suppliers/
distributors
- Market research and consulting firms
- Government bodies such as regulating
authorities and policy makers
- Organizations, forums and alliances related to
betamethasone
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as manufacturers,
suppliers and partners, end users, etc., besides allowing them in strategizing
investments and capitalizing on market opportunities.
Report Scope:
In this report, India betamethasone market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Betamethasone Market, By Source:
- In-House
- Contract
Manufacturing Organizations
- India Betamethasone Market, By Type:
- Betamethasone
Dipropionate
- Betamethasone
Sodium Phosphate
- Betamethasone
Valerate
- India Betamethasone Market, By Form:
- Cream
- Ointment
& Lotion
- Injection-Solution
- Spray
& Foam
- Others
- India Betamethasone Market, By Route of Administration:
- Parenteral
- Ophthalmic
- Topical
- Infiltration
- Intra-articular/Intralesional/Intramuscular
- India Betamethasone Market, By Distribution Channel:
- India Betamethasone Market, By Application:
- Eczema
- Psoriasis
- Dermatitis
- Others
- India Betamethasone Market, By End User:
- Hospitals
& Clinics
- Homecare
- India Betamethasone Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India betamethasone market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
India Betamethasone market is
an upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]